Rafferty Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.36M Buy
104,212
+17,849
+21% +$661K 0.01% 498
2025
Q4
$3.64M Sell
86,363
-8,152
-9% -$329K 0.01% 517
2025
Q3
$3.24M Sell
94,515
-14,307
-13% -$410K 0.01% 530
2025
Q2
$2.94M Sell
108,822
-2,147
-2% -$62.2K 0.01% 506
2025
Q1
$3.29M Buy
110,969
+20,617
+23% +$786K 0.01% 458
2024
Q4
$3.58M Sell
90,352
-75
-0.1% -$2.84K 0.01% 479
2024
Q3
$3.08M Sell
90,427
-19,677
-18% -$554K 0.01% 532
2024
Q2
$2.39M Sell
110,104
-198,455
-64% -$4.17M 0.01% 598
2024
Q1
$6.84M Buy
308,559
+149,094
+93% +$3.64M 0.03% 382
2023
Q4
$4.39M Sell
159,465
-52,956
-25% -$1.28M 0.02% 476
2023
Q3
$4.74M Sell
212,421
-30,981
-13% -$797K 0.03% 395
2023
Q2
$6.2M Sell
243,402
-47,344
-16% -$1.15M 0.04% 366
2023
Q1
$6.48M Buy
290,746
+9,018
+3% +$218K 0.04% 316
2022
Q4
$6.69M Sell
281,728
-63,889
-18% -$1.48M 0.06% 313
2022
Q3
$5.74M Buy
345,617
+146,636
+74% +$3.3M 0.06% 308
2022
Q2
$3.96M Sell
198,981
-25,782
-11% -$521K 0.04% 331
2022
Q1
$6.2M Buy
224,763
+90,313
+67% +$2.58M 0.04% 320
2021
Q4
$5.54M Buy
134,450
+70,418
+110% +$3.11M 0.03% 350
2021
Q3
$2.97M Sell
64,032
-8,143
-11% -$355K 0.02% 483
2021
Q2
$2.89M Buy
72,175
+8,681
+14% +$371K 0.02% 511
2021
Q1
$3.41M Buy
63,494
+47,928
+308% +$2.76M 0.02% 405
2020
Q4
$762K Sell
15,566
-29,405
-65% -$1.36M 0.01% 586
2020
Q3
$1.46M Buy
44,971
+23,330
+108% +$742K 0.02% 503
2020
Q2
$561K Buy
+21,641
New +$539K 0.01% 687
2020
Q1
Sell
-54,478
Closed -$1.52M 801
2019
Q4
$1.52M Sell
54,478
-63,170
-54% -$1.64M 0.02% 454
2019
Q3
$2.82M Buy
117,648
+29,487
+33% +$784K 0.04% 243
2019
Q2
$2.51M Buy
88,161
+42,734
+94% +$1.07M 0.04% 298
2019
Q1
$1.14M Buy
+45,427
New +$867K 0.02% 526

Other funds holding VCYT

Rafferty Asset Management's VCYT Position: Q1 2026 in Review

Rafferty Asset Management increased its Veracyte (VCYT) stake by 21% in Q1 2026, buying an estimated $661K and bringing the position to 104,212 shares worth $3.36M. The position accounts for 0.01% of the portfolio, ranked #498.

Rafferty Asset Management first reported a position in VCYT in Q1 2019 and has held it in 28 quarters since. The position peaked at $6.84M in Q1 2024. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Rafferty Asset Management held 104,212 shares of Veracyte worth $3.36M as of Q1 2026.
  • Rafferty Asset Management bought 17,849 Veracyte shares in Q1 2026, an estimated $661K.
  • Veracyte made up 0.01% of Rafferty Asset Management's portfolio in Q1 2026, its #498 holding.
  • Rafferty Asset Management first reported a position in Veracyte in Q1 2019 and has held it in 28 quarters since.
  • Rafferty Asset Management's Veracyte position peaked at $6.84M in Q1 2024.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.